Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Van Snick

Showing results (41-50 of 131) with videos related to

Pageof 14
Sort By:
European Journal of Immunology|April 1, 1988
Synergistic activation of human T cells by interleukin 1 and interleukin 6F A Houssiau, P G Coulie, D Olive, et al.
Infection and Immunity|July 23, 1998
Interleukin-9 enhances resistance to the intestinal nematode Trichuris murisH Faulkner, J C Renauld, J Van Snick, et al.
Current Topics in Microbiology and Immunology|January 1, 1988
B and T cell responses induced by interleukin-6J Van Snick, A Vink, C Uyttenhove, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1988
Plasmacytoma growth factor activity of murine granulocyte-macrophage colony-stimulating factorA Vink, P Vandenabeele, C Uyttenhove, et al.
European Journal of Immunology|January 1, 1987
Interleukin 1 and poly(rI).poly(rC) induce production of a hybridoma growth factor by human fibroblastsJ Van Damme, S Cayphas, G Opdenakker, et al.
Journal of Leukocyte Biology|March 1, 1995
Interleukin-9 and its receptor: involvement in mast cell differentiation and T cell oncogenesisJ C Renauld, A Kermouni, A Vink, et al.
The Journal of Experimental Medicine|February 1, 1984
Rheumatoid factors in 129XB recombinant inbred strains. Igh-1-linked control of allotypic and isotypic specificitiesJ Van Snick, J P Coutelier, E Van Roost, et al.
Cancer Investigation|January 1, 1993
Interleukin-9: a T-cell growth factor with a potential oncogenic activityJ C Renauld, F Houssiau, C Uyttenhove, et al.
European Journal of Biochemistry|September 1, 1986
Reaction of phosphofructokinase 2/fructose 2,6-bisphosphatase with monoclonal antibodies. A proof of the bifunctionality of the enzymeE Van Schaftingen, P G Coulie, J Van Snick, et al.
European Journal of Immunology|November 1, 1982
Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. V. H-2 associativity of variant-specific antigensJ Van Snick, J Maryanski, A Van Pel, et al.
Pageof 14

Showing results (41-50 of 131) with videos related to

Sort By:
Pageof 14
European Journal of Immunology|April 1, 1988
Synergistic activation of human T cells by interleukin 1 and interleukin 6F A Houssiau, P G Coulie, D Olive, et al.
Infection and Immunity|July 23, 1998
Interleukin-9 enhances resistance to the intestinal nematode Trichuris murisH Faulkner, J C Renauld, J Van Snick, et al.
Current Topics in Microbiology and Immunology|January 1, 1988
B and T cell responses induced by interleukin-6J Van Snick, A Vink, C Uyttenhove, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1988
Plasmacytoma growth factor activity of murine granulocyte-macrophage colony-stimulating factorA Vink, P Vandenabeele, C Uyttenhove, et al.
European Journal of Immunology|January 1, 1987
Interleukin 1 and poly(rI).poly(rC) induce production of a hybridoma growth factor by human fibroblastsJ Van Damme, S Cayphas, G Opdenakker, et al.
Journal of Leukocyte Biology|March 1, 1995
Interleukin-9 and its receptor: involvement in mast cell differentiation and T cell oncogenesisJ C Renauld, A Kermouni, A Vink, et al.
The Journal of Experimental Medicine|February 1, 1984
Rheumatoid factors in 129XB recombinant inbred strains. Igh-1-linked control of allotypic and isotypic specificitiesJ Van Snick, J P Coutelier, E Van Roost, et al.
Cancer Investigation|January 1, 1993
Interleukin-9: a T-cell growth factor with a potential oncogenic activityJ C Renauld, F Houssiau, C Uyttenhove, et al.
European Journal of Biochemistry|September 1, 1986
Reaction of phosphofructokinase 2/fructose 2,6-bisphosphatase with monoclonal antibodies. A proof of the bifunctionality of the enzymeE Van Schaftingen, P G Coulie, J Van Snick, et al.
European Journal of Immunology|November 1, 1982
Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. V. H-2 associativity of variant-specific antigensJ Van Snick, J Maryanski, A Van Pel, et al.
Pageof 14